HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients

Table 5

Main results of the studies with reference to HCV, IR, and adiponectin.

Author, year, ref	HCV (𝑛)	Controls (𝑛)	Confounding factors (%)	HOMA-IR	Adiponectin
				(HCV versus controls)	(HCV versus controls)
	11		Cirrhosis (0)	No information	Similar
Lu et al., 2005 [23]	10 HBV	21	DM (0)
			Obesity—no information
	30	30	Cirrhosis (0)	Similar	Similar
Aksõz et al., 2008 [22]			DM (0)
			Obesity (0)
	30	30 HBV	Cirrhosis (0)	Similar	Similar
Tanaka et al., 2008 [25]			DM (0)
			Obesity (0)
	154	75	Cirrhosis (0)	Higher in HCV	Similar
Cua et al., 2007 [26]			DM (0)
			Obesity—no information
	51	24	Cirrhosis (0)	No information	Similar
Tiftikci et al., 2009 [27]			DM—no information
			Obesity—no information
Zografos et al., 2008 [28]	83	43	No information	No information	No information
	81	40	Cirrhosis (34)	Higher in HCV	Higher in HCV
Hung et al., 2009 [21]			F3/F4
			DM (0)
			Obesity—no information
	94	29	Cirrhosis (0)	Higher in HCV	Higher in HCV
Present study/2011			DM (0)
			Obesity (0)